Latest: FDA Approves New Biosimilar for Oncology Treatment

The Complement Connection in Guillain-Barre and Chronic Inflammatory Demyelinating Polyneuropathy

0 Mins
Explore the role of the complement system in autoimmune neuropathies like GBS and CIDP, and discover innovative therapeutic strategies targeting complement pathways.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago